Sign in
WithdrawnNo phase

Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms

Key facts

Who runs it
University of Texas at Austin
Where
Austin, United StatesSee the site
Trial code
Status
Withdrawn
Started
31 Aug 2024
Ended
31 Aug 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Trauma Memory Reactivation
  • Cannabidiol (CBD) Broad-Spectrum Oil
  • Placebo Oil
Record updated
9 January 2024
Why it stopped
The UT IRB determined that CBD oil is being used as a drug as defined by the FDA. Therefore, an IND must be obtained for the use of CBD oil in this research study in accordance with FDA regulations, 21 CFR 312.

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Adults age 18 to 65
  • Fluent in written and spoken English
  • Has access to the internet
  • Access to a camera with video recording capability
  • History of trauma exposure to either a motor vehicle collision (MVC), sexual assault, physical assault, or combat
  • Willingness to refrain from all non-study cannabis use during the study period

Who cannot take part

  • Changes in psychotropic medication (≤ 8 weeks)
  • Currently receiving trauma-focused psychotherapy
  • Presence of significant suicidality or a history of a suicide attempt within the past 6 months
  • History or current alcohol or substance use disorder within the past month
  • History of psychosis within the past 6 months
  • Any medical problem that would preclude participation in the study (e.g., liver or renal abnormalities or disease)
  • Any current medication that would preclude participation in the study (e.g., use of prescribed blood, such as warfarin; use of anti-seizure medications, such as valproate, lamotrigine, or clobazam; use of thyroid medications, such as levothyroxine; use of heart rhythm medications, such as amiodarone)
  • History of adverse reaction to CBD oil or other CBD products
  • Allergy to coconut or coconut oil
  • Insufficient emotional reactivity to trauma video clips
  • Pregnant or planning to become pregnant within the next 6 weeks
  • Regular cannabis use

Where in United States

  • The Laboratory for the Study of Anxiety Disorders, The University of Texas at AustinAustin, United States

About the trial

What the trial wants to find out

The purpose of this study is to investigate the effects of cannabidiol (CBD) broad-spectrum oil on memory reconsolidation (memory storage) and trauma-related symptoms in trauma-exposed individuals after exposure to a trauma memory reactivation paradigm.

The 3 groups in the trial

  • CBD-WRTreatment being tested

    300 mg CBD broad-spectrum oil will be administered within the reconsolidation window. Preclinical studies demonstrate that the disruptive effects of CBD oil on memory reconsolidation depend on the timing of pharmacological administration (within 6 hours of memory reactivation). Thus, participants will be asked to take a single 300mg oral dose of CBD broad-spectrum oil immediately after the trauma memory reactivation procedure.

    Treatment: Trauma Memory Reactivation and Cannabidiol (CBD) Broad-Spectrum Oil

  • PBO-WRPlacebo, for comparison

    Placebo oil will be administered within the reconsolidation window. Participants will be asked to take a single dose of an MCT coconut oil placebo solution immediately after the trauma memory reactivation procedure.

    Treatment: Trauma Memory Reactivation and Placebo Oil

  • CBD-ORExisting treatment, for comparison

    300mg CBD broad-spectrum oil will be administered outside of the reconsolidation window. Participants will be asked to take a single 300mg oral dose of CBD broad-spectrum oil approximately 24 hrs after the trauma memory reactivation procedure. Thus, CBD will be administered well beyond the critical period for memory reconsolidation. The inclusion of this third arm provides a more robust test of the specific reconsolidation theory-based study hypotheses and aids in controlling for any nonspecific possible anxiolytic effects of CBD.

    Treatment: Trauma Memory Reactivation and Cannabidiol (CBD) Broad-Spectrum Oil

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Cannabidiol on Memory Reconsolidation and Trauma-Related Symptoms: A Randomized Clinical Trial
Record updated
9 January 2024